|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Net loss from discontinued operations | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss from operations to net cash used by operating activities | |||||
| Depreciation and amortization | |||||
| Amortisation of operating lease right of use assets | |||||
| Gain on disposal of subsidiary | |||||
| Allowances for obsolete inventories, net | |||||
| Impairment of long-live assets | |||||
| Allowance for credit losses, net | |||||
| Share-based compensation | |||||
| Impairment of an intangible asset | |||||
| Deferred tax | |||||
| Other non-current assets | |||||
| Government grants | |||||
| Net change in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Prepaid expenses and other current assets | |||||
| Inventories | |||||
| Accounts payable | |||||
| Other payables and accrued liabilities | |||||
| Related parties | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities - Continuing operations | |||||
| Net cash provided by operating activities - Discontinued operations | |||||
| Net cash (used in)/provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition of property, plant and equipment | |||||
| Proceeds from sale of property, plant and equipment | |||||
| Net cash provided by/(used in) investing activities ( Continuing operations | |||||
| Net cash used in investing activities - Discontinued operations | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities: | |||||
| Proceeds from short-term borrowings | |||||
| Loan received from a shareholder | |||||
| Repayment of loan from a shareholder | |||||
| Repayment of short-term borrowings | |||||
| Repayments of long-term borrowings | |||||
| Government grants | |||||
| Related parties | |||||
| Proceeds from issuance of ordinary shares | |||||
| Payment of capital lease obligation | |||||
| Repayment of finance liabilities | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalent and restricted cash | |||||
| Net increase in cash and cash equivalent and restricted cash | |||||
| Cash and cash equivalents and restricted cash at beginning of period | |||||
| Cash and cash equivalents and restricted cash at end of period | |||||
| Cash and cash equivalents and restricted cash at end of year - Continuing operations | |||||
| Supplemental disclosures of cash flow information: | |||||
| Income taxes paid (refunded) | |||||
| Reconciliation of cash, cash equivalents and restricted cash in consolidated statements of cash flows | |||||
| Restricted cash | |||||
| Cash and cash equivalents | |||||
| Cash, cash equivalents and restricted cash | |||||
Loading...